Skip to main content
. 2018 May 17;9(7):865–873. doi: 10.1111/1759-7714.12763

Table 2.

Variables in equation

B SE Wald df Sig. Exp(B) 95% CI applied to Exp(B)
Lower Upper
X1: Gender −0.195 0.469 0.173 1 0.678 0.823 0.329 2.062
X2: Age 0.013 0.017 0.610 1 0.435 1.013 0.981 1.047
X3: Pathological type 0.212 0.352 0.363 1 0.547 1.237 0.620 2.467
X4: Number of lesions −0.018 0.211 0.007 1 0.931 0.982 0.649 1.485
X5: Sum of tumor diameters before treatment 0.370 0.251 2.171 1 0.141 1.448 0.885 2.370
X6: Sum of peritumoral edema diameters before treatment 0.335 0.229 2.140 1 0.144 1.398 0.892 2.189
X7: Maximum value of sum of metastasis diameters 0.203 0.156 1.705 1 0.192 1.225 0.903 1.663
X8: Time of appearance of maximum value of sum of metastasis diameters −0.032 0.029 1.177 1 0.278 0.969 0.915 1.026
X9: Presence of radiological tumor progression during brain metastasis treatment −0.838 0.354 5.596 1 0.018 0.432 0.216 0.866
x10: Maximum value of sum of peritumoral edema diameters −0.110 0.104 1.116 1 0.291 0.896 0.731 1.098
x11: Time of appearance of maximum value of sum of peritumoral edema diameters −0.139 0.043 10.637 1 0.001 0.870 0.801 0.946
x12: Number of appearances of Cho/Cr > 2 −0.245 0.301 0.663 1 0.416 0.783 0.434 1.412
X13: Number of island (yu‐yuan) signs −1.293 0.488 7.038 1 0.008 0.274 0.106 0.713
X14: Number of appearances of high‐signal rings in T2 FLAIRs 0.546 0.486 1.263 1 0.261 1.727 0.666 4.480

CI, confidence interval; FLAIR, fluid‐attenuated inversion recovery; SE, standard error.